Skip to content

Application of Target-Controlled Propofol Infusion in Chinese women undergoing caesarean section

Precision of Target-Controlled Propofol Infusion in Chinese women undergoing semi-elective/planned caesarean section and laparoscopic operation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021094
Enrollment
Unknown
Registered
2019-01-28
Start date
2019-02-08
Completion date
Unknown
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anesthesia drugs

Interventions

Group 2:Laparoscopic surgery
Group 1:Cesarean section

Sponsors

Women's Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
28 Years to 40 Years

Inclusion criteria

Inclusion criteria: All the patients must been evaluated with American Society of Anesthesiologists physical status I or II. The age of mothers in cesarean delivery group and the laparoscopic group ranged from 28 to 40 years old. The pregnancy duration of them ranged from 38 to 41 weeks.

Exclusion criteria

Exclusion criteria: Exclusion criteria included suspected fetal congenital abnormalities, known allergies to anesthetic drugs and constituents, emergency caesarean section and pregnancy duration of less than 33 weeks, severe physiological impairments, chronic use of sedatives or opioids. General anesthesia was required because existing contraindications of regional anesthesia, failure of regional anesthesia or patients refusing of regional anesthesia.

Design outcomes

Primary

MeasureTime frame
drug concentration of propofol;

Countries

China

Contacts

Public ContactXiaowei Qian

Women's Hospital, School of Medicine, Zhejiang University

qxwzhejiangedu@163.com+86 15700157161

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026